BEP on Your Chart: — What the Three Letters Mean

The number depends on the stage and risk category of your disease, which your oncologist determines from blood tumour markers, imaging and histology. Typical courses involve three to four cycles, but the number for your case is specific to your diagnosis. Ask your oncologist which risk category you fall into and how that drives the plan — that is a reasonable question to ask directly and to have answered in writing.

Yes. Hair loss from chemotherapy is almost always temporary. It typically begins in the early weeks of treatment and affects the whole body, not only the scalp. Regrowth usually starts within weeks of the final cycle finishing. Texture or colour can be slightly different at first, but full regrowth is the expected outcome for the majority of people. If hair loss is a significant concern before treatment begins, ask your team about a referral to an oncology social worker or support service.

Some treatment days — particularly those involving the cisplatin infusion with its required hours of IV hydration — may require a short admission depending on your treating centre and your individual situation. Other elements can be given as outpatient day care. Your team will explain the schedule before you start, including which days require you to attend and for how long, so you can plan accordingly.

Many people reduce or pause work during BEP, particularly in the days after each treatment dose when fatigue and nausea tend to be greatest. Whether you can continue working depends on your job, how your body responds to treatment, and whether you have the flexibility to attend same-day reviews if needed. Discuss this with your oncologist before the first cycle — do not wait until you are mid-treatment to realise you needed more time off.

Your team will arrange follow-up visits and blood tumour marker tests at regular intervals after treatment ends. The same markers used to diagnose and stage your disease are the ones monitored in follow-up. These visits continue for several years and are an active part of care. Your oncologist will explain the follow-up schedule specific to your staging and what changes in marker levels would prompt further investigation.

Yes — keeping a record of your treatment matters well beyond the end of active care. Future doctors, including anaesthetists, need to know you received bleomycin, because it affects how certain concentrations of oxygen can safely be used during anaesthesia. Cisplatin-related hearing and nerve effects can also be relevant to future medical decisions. Ask for a treatment summary in writing before leaving the care of your treating team, so that information is available throughout your life.